deferiprone has been researched along with Diabetic Cardiomyopathies in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone treatment reduced iron deposition and IR in DC rats except for blood glucose." | 1.46 | Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. ( Bao, Y; Jia, X; Jin, Q; Li, L; Liu, R; Liu, X; Xie, R; Zou, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zou, C | 1 |
| Liu, X | 1 |
| Xie, R | 1 |
| Bao, Y | 1 |
| Jin, Q | 1 |
| Jia, X | 1 |
| Li, L | 1 |
| Liu, R | 1 |
1 other study available for deferiprone and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats.
Topics: Animals; Deferiprone; Diabetic Cardiomyopathies; Dose-Response Relationship, Drug; Endomyocardial Fi | 2017 |